ArticleBMC cancer2013

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.

Quan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.